The liver can regenerate, but certain risk factors (genetic or lifestyle) contribute to an increasing prevalence of liver cancer, in an era where most cancers are decreasing. Changes have been made to address this, but there are few treatment options for people diagnosed at the advanced stage; especially for those with hepatocellular carcinoma (HCC), the primary type of liver cancer.

Hepatocellular carcinoma – the ‘silent killer’ (Part 2)

How did Taiwan halve the incidence of HCC in a decade? 72% of cases are diagnosed in Asia, where big steps have been taken to address this challenge.

Tags: Science, Patients, Innovation